César Augusto
Rodríguez Sánchez
Profesor Asociado CC. Salud
![Foto de César Augusto](/img/nophoto.png)
![Foto de Institute Catalá Oncología](/img/noimage_org.png)
Institute Catalá Oncología
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Institute Catalá Oncología (11)
2022
2021
2020
-
Phase III study to evaluate patient’s preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07)
European Journal of Cancer Care, Vol. 29, Núm. 4
2019
-
Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients
Aging, Vol. 11, Núm. 9, pp. 2874-2888
-
Neoadjuvant metformin added to systemic therapy decreases the proliferative capacity of residual breast cancer
Journal of Clinical Medicine, Vol. 8, Núm. 12
-
The C allele of ATM rs11212617 associates with higher pathological complete remission rate in breast cancer patients treated with neoadjuvant metformin
Frontiers in Oncology, Vol. 9, Núm. MAR
2018
-
A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: The METTEN study
Oncotarget, Vol. 9, Núm. 86, pp. 35687-35704
-
Long-term response to first-line bevacizumab-based therapy in patients with metastatic breast cancer: Results of the observational “LORENA” study
OncoTargets and Therapy, Vol. 11, pp. 5845-5852
2014
-
SEOM clinical guidelines for the treatment of renal cell carcinoma
Clinical and Translational Oncology, Vol. 16, Núm. 12, pp. 1043-1050
2011
-
Psychometric properties of the Perform Questionnaire: A brief scale for assessing patient perceptions of fatigue in cancer
Supportive Care in Cancer, Vol. 19, Núm. 5, pp. 657-666
2009
-
Development of a new questionnaire to assess patient perceptions of cancer-related fatigue: Item generation and item reduction
Value in Health, Vol. 12, Núm. 1, pp. 130-138